These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26952295)

  • 1. Modified In Vivo Lung Perfusion for Local Chemotherapy: A Preclinical Study With Doxorubicin.
    Reck Dos Santos P; Sakamoto J; Chen M; Linacre V; Arce C; Liu M; Waddell TK; Keshavjee S; Cypel M
    Ann Thorac Surg; 2016 Jun; 101(6):2132-40. PubMed ID: 26952295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified in vivo lung perfusion allows for prolonged perfusion without acute lung injury.
    dos Santos PR; Iskender I; Machuca T; Hwang D; dePerrot M; Liu M; Keshavjee S; Waddell TK; Cypel M
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):774-81: discussion 781-2. PubMed ID: 24290703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo lung perfusion rehabilitates sepsis-induced lung injury.
    Mehaffey JH; Charles EJ; Schubert S; Salmon M; Sharma AK; Money D; Stoler MH; Laubach VE; Tribble CG; Roeser ME; Kron IL
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):440-448.e2. PubMed ID: 29033043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model to assess acute and delayed lung toxicity of oxaliplatin during in vivo lung perfusion.
    Ramadan K; Gomes B; Pipkin M; Olkowicz M; Bojko B; Mbadjeu Hondjeu AR; Keshavjee S; Waddell T; Pawliszyn J; Cypel M
    J Thorac Cardiovasc Surg; 2021 May; 161(5):1626-1635. PubMed ID: 32354628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion.
    Bojko B; Looby N; Olkowicz M; Roszkowska A; Kupcewicz B; Reck Dos Santos P; Ramadan K; Keshavjee S; Waddell TK; Gómez-Ríos G; Tascon M; Goryński K; Cypel M; Pawliszyn J
    J Pharm Anal; 2021 Feb; 11(1):37-47. PubMed ID: 33717610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two Hours of In Vivo Lung Perfusion Improves Lung Function in Sepsis-Induced Acute Respiratory Distress Syndrome.
    Byler MR; Haywood NS; Money DT; Zhang A; Beller JP; Charles EJ; Chancellor WZ; Ta HQ; Stoler MH; Mehaffey JH; Laubach VE; Kron IL; Roeser ME
    Semin Thorac Cardiovasc Surg; 2022; 34(1):337-346. PubMed ID: 33713831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: II. High-dose cisplatin is well tolerated by the native lung tissue.
    Franke UF; Wittwer T; Kaluza M; Albert M; Becker V; Roskos M; Lessel M; Wahlers T
    Eur J Cardiothorac Surg; 2004 Oct; 26(4):800-6. PubMed ID: 15450576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional chemotherapy via pulmonary artery with blood flow occlusion in a solitary tumor nodule model.
    Wang HY; Hochwald S; Ng B; Burt M
    Anticancer Res; 1996; 16(6B):3749-53. PubMed ID: 9042252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytostatic lung perfusion by use of an endovascular blood flow occlusion technique.
    Furrer M; Lardinois D; Thormann W; Altermatt HJ; Betticher D; Triller J; Mettler D; Althaus U; Burt ME; Ris HB
    Ann Thorac Surg; 1998 Jun; 65(6):1523-8. PubMed ID: 9647052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytostatic lung perfusion results in heterogeneous spatial regional blood flow and drug distribution: evaluation of different cytostatic lung perfusion techniques in a porcine model.
    Krueger T; Kuemmerle A; Kosinski M; Denys A; Magnusson L; Stupp R; Delaloye AB; Klepetko W; Decosterd L; Ris HB; Dusmet M
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):304-11. PubMed ID: 16872954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated lung perfusion: single-pass system versus recirculating blood perfusion in pigs.
    Furrer M; Lardinois D; Thormann W; Altermatt HJ; Betticher D; Cerny T; Fikrle A; Mettler D; Althaus U; Burt ME; Ris HB
    Ann Thorac Surg; 1998 May; 65(5):1420-5. PubMed ID: 9594878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site.
    Mürdter TE; Sperker B; Kivistö KT; McClellan M; Fritz P; Friedel G; Linder A; Bosslet K; Toomes H; Dierkesmann R; Kroemer HK
    Cancer Res; 1997 Jun; 57(12):2440-5. PubMed ID: 9192823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic fate of oxaliplatin in the biological milieu investigated during
    Olkowicz M; Rosales-Solano H; Ramadan K; Wang A; Cypel M; Pawliszyn J
    Front Cell Dev Biol; 2022; 10():928152. PubMed ID: 36092704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated single-lung perfusion: a study of the optimal perfusate and other pharmacokinetic factors.
    Weksler B; Ng B; Lenert JT; Burt ME
    Ann Thorac Surg; 1995 Sep; 60(3):624-9. PubMed ID: 7545890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary toxicity of doxorubicin administered by in situ isolated lung perfusion in dogs.
    Minchin RF; Johnston MR; Schuller HM; Aiken MA; Boyd MR
    Cancer; 1988 Apr; 61(7):1320-5. PubMed ID: 2830958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemofiltration in ex vivo lung perfusion-a study in experimentally induced pulmonary edema.
    Nilsson T; Hansson C; Wallinder A; Malm CJ; Silverborn M; Ricksten SE; Dellgren G
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):570-5.e1. PubMed ID: 26219590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo lung perfusion for prompt recovery from primary graft dysfunction after lung transplantation.
    Matsubara K; Miyoshi K; Kawana S; Kubo Y; Shimizu D; Tomioka Y; Shiotani T; Yamamoto H; Tanaka S; Kurosaki T; Ohara T; Okazaki M; Sugimoto S; Matsukawa A; Toyooka S
    J Heart Lung Transplant; 2024 Feb; 43(2):284-292. PubMed ID: 37852513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin, ifosfamide, and dacarbazine (AID) with mesna uroprotection for advanced untreated sarcoma: a phase I study.
    Elias AD; Antman KH
    Cancer Treat Rep; 1986 Jul; 70(7):827-33. PubMed ID: 3087617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group.
    Le Cesne A; Judson I; Crowther D; Rodenhuis S; Keizer HJ; Van Hoesel Q; Blay JY; Frisch J; Van Glabbeke M; Hermans C; Van Oosterom A; Tursz T; Verweij J
    J Clin Oncol; 2000 Jul; 18(14):2676-84. PubMed ID: 10894866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.
    Maurel J; López-Pousa A; de Las Peñas R; Fra J; Martín J; Cruz J; Casado A; Poveda A; Martínez-Trufero J; Balañá C; Gómez MA; Cubedo R; Gallego O; Rubio-Viqueira B; Rubió J; Andrés R; Sevilla I; de la Cruz JJ; Del Muro XG; Buesa JM
    J Clin Oncol; 2009 Apr; 27(11):1893-8. PubMed ID: 19273704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.